Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 27

1.

Exploring Valrubicin's Effect on Propionibacterium Acnes-Induced Skin Inflammation in Vitro and in Vivo.

Rottboell L, de Foenss S, Thomsen K, Christiansen H, Andersen SM, Dam TN, Rosada C, Stenderup K.

Dermatol Reports. 2015 Dec 17;7(3):6246. doi: 10.4081/dr.2015.6246. eCollection 2015 Dec 3.

2.

AZ17: a new bispecific drug targeting IL-6 and IL-23 with potential clinical use--improves psoriasis in a human xenograft transplantation model.

Stenderup K, Rosada C, Shanebeck K, Brady W, Van Brunt MP, King G, Marelli M, Slagle P, Xu H, Nairn NW, Johnson J, Wang AA, Li G, Thornton KC, Dam TN, Grabstein KH.

Protein Eng Des Sel. 2015 Oct;28(10):467-80. doi: 10.1093/protein/gzv034. Epub 2015 Aug 12.

PMID:
26271488
3.

Robust Lentiviral Gene Delivery But Limited Transduction Capacity of Commonly Used Adeno-Associated Viral Serotypes in Xenotransplanted Human Skin.

Jakobsen M, Askou AL, Stenderup K, Rosada C, Dagnæs-Hansen F, Jensen TG, Corydon TJ, Mikkelsen JG, Aagaard L.

Hum Gene Ther Methods. 2015 Aug;26(4):123-33. doi: 10.1089/hgtb.2014.135.

PMID:
26204415
4.

The role of leptin in psoriasis comprises a proinflammatory response by the dermal fibroblast.

Ommen P, Stjernholm T, Kragstrup T, Raaby L, Johansen C, Stenderup K, Iversen L, Rosada C.

Br J Dermatol. 2016 Jan;174(1):187-90. doi: 10.1111/bjd.13969. Epub 2015 Nov 8. No abstract available.

PMID:
26119283
5.

Debio 0932, a new oral Hsp90 inhibitor, alleviates psoriasis in a xenograft transplantation model.

Stenderup K, Rosada C, Gavillet B, Vuagniaux G, Dam TN.

Acta Derm Venereol. 2014 Nov;94(6):672-6. doi: 10.2340/00015555-1838.

6.

Valrubicin activates PKCa in keratinocytes: a conceivable mode of action in treating hyper-proliferative skin diseases.

Laugesen IG, Hauge E, Andersen SM, Stenderup K, de Darkó E, Dam TN, Rosada C.

J Drugs Dermatol. 2013 Oct;12(10):1156-62.

PMID:
24085052
7.

A lentiviral vector-based genetic sensor system for comparative analysis of permeability and activity of vitamin D3 analogues in xenotransplanted human skin.

Staunstrup NH, Bak RO, Cai Y, Svensson L, Petersen TK, Rosada C, Stenderup K, Bolund L, Mikkelsen JG.

Exp Dermatol. 2013 Mar;22(3):178-83. doi: 10.1111/exd.12091.

PMID:
23489420
8.

Topical valrubicin application reduces skin inflammation in murine models.

Hauge E, Christiansen H, Rosada C, de Darkó E, Dam TN, Stenderup K.

Br J Dermatol. 2012 Aug;167(2):288-95. doi: 10.1111/j.1365-2133.2012.10964.x. Epub 2012 Jul 5.

PMID:
22458650
9.

Stereological estimation of epidermal volumes and dermo-epidermal surface area in normal skin.

Kamp S, Balkert LS, Stenderup K, Rosada C, Pakkenberg B, Kemp K, Jemec GB, Dam TN.

Dermatology. 2011;223(2):131-9. doi: 10.1159/000330737. Epub 2011 Sep 13.

PMID:
21921579
10.

Resolution of psoriasis by a leukocyte-targeting bacterial protein in a humanized mouse model.

Stenderup K, Rosada C, Dam TN, Salerno E, Belinka BA, Kachlany SC.

J Invest Dermatol. 2011 Oct;131(10):2033-9. doi: 10.1038/jid.2011.161. Epub 2011 Jun 9.

11.

Statistical evaluation and experimental design of a psoriasis xenograft transplantation model treated with cyclosporin A.

Stenderup K, Rosada C, Alifrangis L, Andersen S, Dam TN.

Exp Dermatol. 2011 May;20(5):441-4. doi: 10.1111/j.1600-0625.2011.01251.x. Epub 2011 Mar 22.

PMID:
21426413
12.

Targeting of human interleukin-12B by small hairpin RNAs in xenografted psoriatic skin.

Bak RO, Stenderup K, Rosada C, Petersen LB, Moldt B, Dagnæs-Hansen F, Jakobsen M, Kamp S, Jensen TG, Dam TN, Mikkelsen JG.

BMC Dermatol. 2011 Feb 27;11:5. doi: 10.1186/1471-5945-11-5.

13.

Dimethylfumarate inhibits MIF-induced proliferation of keratinocytes by inhibiting MSK1 and RSK1 activation and by inducing nuclear p-c-Jun (S63) and p-p53 (S15) expression.

Gesser B, Rasmussen MK, Raaby L, Rosada C, Johansen C, Kjellerup RB, Kragballe K, Iversen L.

Inflamm Res. 2011 Jul;60(7):643-53. doi: 10.1007/s00011-011-0316-7. Epub 2011 Feb 22.

PMID:
21340650
14.

Hidradenitis suppurativa: a disease of the absent sebaceous gland? Sebaceous gland number and volume are significantly reduced in uninvolved hair follicles from patients with hidradenitis suppurativa.

Kamp S, Fiehn AM, Stenderup K, Rosada C, Pakkenberg B, Kemp K, Dam TN, Jemec GB.

Br J Dermatol. 2011 May;164(5):1017-22. doi: 10.1111/j.1365-2133.2011.10224.x.

PMID:
21250966
15.

Topical application of valrubicin has a beneficial effect on developing skin tumors.

Andersen SM, Rosada C, Dagnaes-Hansen F, Laugesen IG, de Darkó E, Dam TN, Stenderup K.

Carcinogenesis. 2010 Aug;31(8):1483-90. doi: 10.1093/carcin/bgq122. Epub 2010 Jun 16.

16.

Valrubicin in a topical formulation treats psoriasis in a xenograft transplantation model.

Rosada C, Stenderup K, de Darkó E, Dagnaes-Hansen F, Kamp S, Dam TN.

J Invest Dermatol. 2010 Feb;130(2):455-63. doi: 10.1038/jid.2009.277. Epub 2009 Sep 10.

17.

Amelioration of psoriasis by anti-TNF-alpha RNAi in the xenograft transplantation model.

Jakobsen M, Stenderup K, Rosada C, Moldt B, Kamp S, Dam TN, Jensen TG, Mikkelsen JG.

Mol Ther. 2009 Oct;17(10):1743-53. doi: 10.1038/mt.2009.141. Epub 2009 Jun 30.

18.

Interleukin-20 plays a critical role in maintenance and development of psoriasis in the human xenograft transplantation model.

Stenderup K, Rosada C, Worsaae A, Dagnaes-Hansen F, Steiniche T, Hasselager E, Iversen LF, Zahn S, Wöldike H, Holmberg HL, Rømer J, Kragballe K, Clausen JT, Dam TN.

Br J Dermatol. 2009 Feb;160(2):284-96. doi: 10.1111/j.1365-2133.2008.08890.x. Epub 2008 Oct 20.

PMID:
18945296
19.

[Interleukin-20--a new target in psoriasis treatment].

Stenderup K, Rosada C, Dam TN.

Ugeskr Laeger. 2008 Sep 1;170(36):2777-81. Review. Danish.

PMID:
18761871
20.

Interleukin-20 as a target in psoriasis treatment.

Stenderup K, Rosada C, Worsaae A, Clausen JT, Norman Dam T.

Ann N Y Acad Sci. 2007 Sep;1110:368-81. Review.

PMID:
17911452
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk